The discovery offers researchers and scientists a new target for treatments of neurological diseases sparked by acute viral infections.
The findings from researchers at McMaster and the University of Maryland could lead many hospitals to consider a policy change regarding what they use before fracture surgeries.
Anthony Levinson, from Psychiatry & Behavioural Neurosciences talks about the disease's effects and symptoms, as well as changes to watch for.